Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Murfreesboro
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Murfreesboro, TN

Studies commonly pay $75 to $4,500 per completed study

77 clinical trials are currently recruiting participants within 30 miles of Murfreesboro. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

77studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Murfreesboro right now

Top 25 of 77 recruiting studies, sorted by proximity — each links to its official registry page

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Phase 3 Interventional 1,410 participants sought
Tennessee Oncology, PLLC - Murfreesboro — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07222566)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
International Clinical Research Tennessee Llc — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Abnormal Uterine Bleeding (AUB), Endometrial Cancer N/A Observational 4,200 participants sought
Murfreesboro Medical Clinic — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Exact Sciences Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07544680)

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis Phase 2 Interventional 284 participants sought
Clinical Trials Center of Middle Tennessee — Franklin, Tennessee (26.1 mi) · Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
See eligibility & contact on ClinicalTrials.gov (NCT06559150)

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF) Phase 3 Interventional 1,100 participants sought
Clinical Trials Center of Middle Tennesee LLC — Franklin, Tennessee (26.1 mi) · Sponsor: PureTech
See eligibility & contact on ClinicalTrials.gov (NCT07284602)

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) Phase 2 Interventional 315 participants sought
Psychiatric Consultants - Franklin /ID# 275133 — Franklin, Tennessee (26.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06846320)

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Plaque Psoriasis Phase 3 Interventional 3,040 participants sought
International Clinical Research (IC Research) - Murfreesboro — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07116967)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Vanderbilt-Ingram Cancer Center at Franklin — Franklin, Tennessee (26.1 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06580314)

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Locally Advanced Breast Cancer Phase 3 Interventional 1,000 participants sought
Clinical Trial Site — Mount Juliet, Tennessee (25.0 mi) · Sponsor: Olema Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07085767)

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

Non-segmental Vitiligo Phase 2 Interventional 210 participants sought
International Clinical Research Tennessee LCC — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07431177)

Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

Limbal Stem Cell Deficiency N/A Observational 500 participants sought
Claris Investigative Site — Smyrna, Tennessee (11.0 mi) · Sponsor: Claris Biotherapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07636590)

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Acne Phase 1, Phase 2 Interventional 800 participants sought
DelRicht Research - Thompson's Station- Site Number : 8400041 — Smyrna, Tennessee (11.0 mi) · Sponsor: Sanofi Pasteur, a Sanofi Company
See eligibility & contact on ClinicalTrials.gov (NCT06316297)

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Liver Diseases, Alcoholic Phase 2 Interventional 393 participants sought
GSK Investigational Site — Hermitage, Tennessee (26.7 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT06613698)

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

Sjögren's Syndrome Phase 3 Interventional 844 participants sought
Murfreesboro Medical Clinic Westlawn — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT06747949)

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) Phase 2, Phase 3 Interventional 210 participants sought
DelRicht Research — Smyrna, Tennessee (11.0 mi) · Sponsor: Bluefin Biomedicine, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07287644)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought
Akero Clinical Study Site — Hermitage, Tennessee (26.7 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06215716)

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Kidney Diseases, Kidney Diseases, Chronic Phase 3 Interventional 220 participants sought
Knoxville Kidney Center Pllc — Brentwood, Tennessee (24.3 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06858319)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Spring Hill, Tennessee (29.8 mi) · Sponsor: TG Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06433752)

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Arthritis, Psoriatic Phase 3 Interventional 600 participants sought
Clinical Site — Murfreesboro, Tennessee (1.2 mi) · Sponsor: MoonLake Immunotherapeutics AG
See eligibility & contact on ClinicalTrials.gov (NCT06641089)

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Alopecia Areata Phase 3 Interventional 355 participants sought
Delricht Research - Smyrna — Smyrna, Tennessee (11.0 mi) · Sponsor: Sun Pharmaceutical Industries, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07133308)
Actively enrolling

Studies you may be able to join near Murfreesboro

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Murfreesboro

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

International Clinical Research-Tennessee, LLC

★ 3.9
1035 N Highland Ave, Murfreesboro, TN 37130
(615) 410-3460
"I participated in an IC Research clinical study for a full year, and I can’t recommend them to anyone. On three separate occasions they failed to dis…"
— Hamid Ashari, 1★

Comprehensive Cancer Center

1840 Medical Center Pkwy, Murfreesboro, TN 37129
(615) 396-5530

MMC — Internal and Family Medicine

★ 4.9
1272 Garrison Dr, Murfreesboro, TN 37129
(615) 867-8010
"Very friendly staff they help you with any questions you may have."
— George R. Mcclain, 4★

Trustpoint Hospital

★ 2.7 (448 reviews)
1009 N Thompson Ln, Murfreesboro, TN 37129
(615) 716-1824
"So ghetto unprofessional don’t return phone calls lady that answered the phone this morning was very unprofessional believe what these reviews say th…"
— Twaina Woods, 1★

DelRicht Research of Thompson's Station Clinical Trials

★ 5.0
521 Stonecrest Pkwy #201, Smyrna, TN 37167
(504) 336-2667
"I absolutely would recommend them. Constance has made a magnificent impact on my short time here. All the nurses and Doctors been knowledgeable about…"
— Jaycie Oldham, 5★

Clinical Trials Center of Middle Tennessee

★ 5.0
100 Covey Dr, Franklin, TN 37067
(615) 205-8350
"We have been coming for over a year, and it has been a life changing experience, everyone is so friendly and helpful and easy to work with."
— Aggie Campbell, 5★

Clinical Research Solutions - Smyrna, TN

515 Stonecrest Pkwy #110, Smyrna, TN 37167
(615) 984-3365

HCCA Clinical Research

515 Stonecrest Pkwy, Smyrna, TN 37167
(615) 462-6346

Southeast Clinical Research

★ 5.0
224 Took Dr, Antioch, TN 37013
(615) 739-6512

Clinical trials in Murfreesboro: what's recruiting

The Murfreesboro area currently has 77 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Murfreesboro, the most active research areas are:

  • Cancer & Oncology6 studies
  • Liver & Kidney3 studies
  • Immune & Skin2 studies
  • Lungs & Breathing1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Murfreesboro, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Murfreesboro

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Murfreesboro participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Murfreesboro pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Murfreesboro?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Murfreesboro?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Murfreesboro.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Murfreesboro typically complete one or two studies per year.

Paid clinical trials near Murfreesboro

Other metros within reach

Nashville, TN1,342 Huntsville, AL92 Clarksville, TN8 Chattanooga, TN146 Birmingham, AL966 Evansville, IN66 Louisville, KY566 Knoxville, TN231

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Murfreesboro Bladder Issues Due To Spinal Cord Injury in Murfreesboro All conditions

More of TN

Nashville1,342 Memphis580 Knoxville231 Chattanooga146 Clarksville8

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts